The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of subsequent chemotherapy on overall survival in first-line chemotherapy with targeted agents for patients with metastatic colorectal cancer: Systematic review and meta-analysis of randomized control trials.
 
Daisuke Sakai
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Toshihiro Kudo
No Relationships to Disclose
 
Aya Kato
No Relationships to Disclose
 
Toshinori Sueda
No Relationships to Disclose
 
Hidekazu Takahashi
No Relationships to Disclose
 
Naotsugu Haraguchi
No Relationships to Disclose
 
Junichi Nishimura
No Relationships to Disclose
 
Taishi Hata
No Relationships to Disclose
 
Chu Matsuda
No Relationships to Disclose
 
Tsunekazu Mizushima
No Relationships to Disclose
 
Yuichiro Doki
No Relationships to Disclose
 
Masaki Mori
No Relationships to Disclose
 
Taroh Satoh
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Lilly; Merck Serono; Ono Pharmaceutical; Takara Bio
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Yakult Honsha (Inst)